Elevated P75NTRexpression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression

Neural Development

Volumn 4, Issue 1, 2009, Pages

  Alavian, Kambiz N ^a,b   Sgadó, Paola ^a,c   Alberi, Lavinia ^a,d   Subramaniam, Srinivasa ^a,e   Simon, Horst H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MCLEAN HOSPITAL   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; EN1 PROTEIN, MOUSE; ENGRAILED 2 PROTEIN; HOMEODOMAIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; TNFRSF16 PROTEIN, MOUSE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL DEATH; DISEASE MODEL; GENETICS; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; METABOLISM; MOUSE; MOUSE MUTANT; MUTATION; NERVE CELL; PARKINSON DISEASE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOPAMINE; HETEROZYGOTE; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 64749085056     PISSN: None     EISSN: 17498104     Source Type: Journal    
DOI: 10.1186/1749-8104-4-11     Document Type: Article

References (67)

1. Getting formal with dopamine and reward. W Schultz, Neuron 2002 36 241 263 10.1016/S0896-6273(02)00967-4 12383780
2. The neurobiology of dopamine signaling. JA Girault P Greengard, Arch Neurol 2004 61 641 644 10.1001/archneur.61.5.641 15148138
3. Expanding insights of mitochondrial dysfunction in Parkinson's disease. PM Abou-Sleiman MM Muqit NW Wood, Nat Rev Neurosci 2006 7 207 219 10.1038/nrn1868 16495942
4. Apoptosis in Parkinson's disease: signals for neuronal degradation. WG Tatton R Chalmers-Redman D Brown N Tatton, Ann Neurol 2003 53 Suppl 3 S61 70 discussion S70-62. 10.1002/ana.10489 12666099
5. Genetics of Parkinson disease: paradigm shifts and future prospects. MJ Farrer, Nat Rev Genet 2006 7 306 318 10.1038/nrg1831 16543934
6. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. A Schober, Cell Tissue Res 2004 318 215 224 10.1007/s00441-004-0938-y 15503155
7. Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. C Perier K Tieu C Guegan C Caspersen V Jackson-Lewis V Carelli A Martinuzzi M Hirano S Przedborski M Vila, Proc Natl Acad Sci USA 2005 102 19126 19131 16365298 10.1073/pnas.0508215102
8. The yin and yang of neurotrophin action. B Lu PT Pang NH Woo, Nat Rev Neurosci 2005 6 603 614 10.1038/nrn1726 16062169
9. TGF-beta and the regulation of neuron survival and death. K Krieglstein J Strelau A Schober A Sullivan K Unsicker, J Physiol Paris 2002 96 25 30 10.1016/S0928-4257(01)00077-8 11755780
10. Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. AL Bhakar JL Howell CE Paul AH Salehi EB Becker F Said A Bonni PA Barker, J Neurosci 2003 23 11373 11381 14673001
11. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. L Alberi P Sgado HH Simon, Development 2004 131 3229 3236 10.1242/dev.01128 15175251
12. Fate of midbrain dopaminergic neurons controlled by the Engrailed genes. HH Simon H Saueressig W Wurst MD Goulding DD O'Leary, J Neurosci 2001 21 3126 3134 11312297
13. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. HH Simon L Bhatt D Gherbassi P Sgado L Alberi, Ann NY Acad Sci 2003 991 36 47 12846972
14. Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. P Sgado L Alberi D Gherbassi SL Galasso GM Ramakers KN Alavian MP Smidt RH Dyck HH Simon, Proc Natl Acad Sci USA 2006 103 15242 15247 17015829 10.1073/pnas.0602116103
15. Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. AL Joyner K Herrup BA Auerbach CA Davis J Rossant, Science 1991 251 1239 1243 10.1126/science.1672471 1672471
16. Engrailed-1 and netrin-1 regulate axon pathfinding by association interneurons that project to motor neurons. H Saueressig J Burrill M Goulding, Development 1999 126 4201 4212 10477289
17. Differential effects of 6-hydroxydopamine-induced ablation of peripheral and central adrenergic axons on C-1300 murine neuroblastoma tumor growth and catecholamine concentration in the A/J mouse. DW Fink PT Horn BL Mirkin, J Pharmacol Exp Ther 1992 262 1070 1075 1527714
18. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. MM Mocanu GF Baxter DM Yellon, Br J Pharmacol 2000 130 197 200 10807653 10.1038/sj.bjp.0703336
19. Direct activation of the apoptosis machinery as a mechanism to target cancer cells. JT Nguyen JA Wells, Proc Natl Acad Sci USA 2003 100 7533 7538 12808146 10.1073/pnas.1031631100
20. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. M Sawada W Sun P Hayes K Leskov DA Boothman S Matsuyama, Nat Cell Biol 2003 5 320 329 10.1038/ncb950 12652308
21. Caspases: enemies within. NA Thornberry Y Lazebnik, Science 1998 281 1312 1316 10.1126/science.281.5381.1312 9721091
22. Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells. B Fadeel Z Hassan E Hellstrom-Lindberg JI Henter S Orrenius B Zhivotovsky, Leukemia 1999 13 719 728 10.1038/sj/leu/2401411 10374876
23. Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation. K Tanaka M Honda T Takabatake, Clin Exp Pharmacol Physiol 2004 31 360 364 10.1111/j.1440-1681.2004.04010.x 15191412
24. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. JL Wang D Liu ZJ Zhang S Shan X Han SM Srinivasula CM Croce ES Alnemri Z Huang, Proc Natl Acad Sci USA 2000 97 7124 7129 10860979 10.1073/pnas.97.13.7124
25. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. JW Langston I Irwin EB Langston LS Forno, Neurosci Lett 1984 48 87 92 10.1016/0304-3940(84)90293-3 6332288
26. The p53 inhibitor pifithrin-alpha is a potent agonist of the aryl hydrocarbon receptor. MS Hoagland EM Hoagland HI Swanson, J Pharmacol Exp Ther 2005 314 603 610 10.1124/jpet.105.084186 15843497
27. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. VJ Bykov N Issaeva A Shilov M Hultcrantz E Pugacheva P Chumakov J Bergman KG Wiman G Selivanova, Nat Med 2002 8 282 288 10.1038/nm0302-282 11875500
28. Neurotrophins induce release of neurotrophins by the regulated secretory pathway. A Kruttgen JC Moller JV Heymach Jr EM Shooter, Proc Natl Acad Sci USA 1998 95 9614 9619 9689129 10.1073/pnas.95.16.9614
29. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. CM Testa TB Sherer JT Greenamyre, Brain Res Mol Brain Res 2005 134 109 118 15790535 10.1016/j.molbrainres.2004.11.007
30. SP60 a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease. W Wang L Shi Y Xie C Ma W Li X Su S Huang R Chen Z Zhu Z Mao Y Han M Li, Neurosci Res 0125 48 195 202 10.1016/j.neures.2003.10.012
31. Ways of dying/multiple pathways to apoptosis. JM Adams, Genes Dev 2003 17 2481 2495 10.1101/gad.1126903 14561771
32. MEK inhibitors: the chemistry and biological activity of U its analogs, and cyclization products. JV Duncia JB Santella 3rd CA Higley WJ Pitts J Wityak WE Frietze FW Rankin JH Sun RA Earl AC Tabaka CA Teleha KF Blom MF Favata EJ Manos AJ Daulerio DA Stradley K Horiuchi RA Copeland PA Scherle JM Trzaskos RL Magolda GL Trainor RR Wexler FW Hobbs RE Olson, Bioorg Med Chem Lett 0126 8 2839 2844 10.1016/S0960-894X(98)00522-8
33. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. DA Martin RM Siegel L Zheng MJ Lenardo, J Biol Chem 1998 273 4345 4349 10.1074/jbc.273.8.4345 9468483
34. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. SM Elbashir J Harborth W Lendeckel A Yalcin K Weber T Tuschl, Nature 2001 411 494 498 10.1038/35078107 11373684
35. Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta. S Thuret L Bhatt DD O'Leary HH Simon, Mol Cell Neurosci 2004 25 394 405 10.1016/j.mcn.2003.11.004 15033168
36. Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. TJ Davidson S Harel VA Arboleda GF Prunell ML Shelanski LA Greene CM Troy, J Neurosci 2004 24 10040 10046 10.1523/JNEUROSCI.3643-04.2004 15537872
37. Growth/Differentiation factor-15/Macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Strelau A Sullivan M Bottner P Lingor E Falkenstein C Suter-Crazzolara D Galter J Jaszai K Krieglstein K Unsicker, J Neurosci 2000 20 8597 8603 11102463
38. A null mutation in TGF-alpha leads to a reduction in midbrain dopaminergic neurons in the substantia nigra. M Blum, Nat Neurosci 1998 1 374 377 10.1038/1584 10196526
39. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. A Tomac E Lindqvist LF Lin SO Ogren D Young BJ Hoffer L Olson, Nature 1995 373 335 339 10.1038/373335a0 7830766
40. p75NTR is positively promiscuous: novel partners and new insights. PA Barker, Neuron 2004 42 529 533 10.1016/j.neuron.2004.04.001 15157416
41. Signaling pathways mediating anti-apoptotic action of neurotrophins. M Hetman Z Xia, Acta Neurobiol Exp (Wars) 2000 60 531 545 11200182
42. Specificity and mechanism of action of some commonly used protein kinase inhibitors. SP Davies H Reddy M Caivano P Cohen, Biochem J 2000 351 95 105 10998351 10.1042/0264-6021:3510095
43. Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases. CM Troy JE Friedman WJ Friedman, J Biol Chem 2002 277 34295 34302 10.1074/jbc.M205167200 12097334
44. Characterization of a p75(NTR) apoptotic signaling pathway using a novel cellular model. X Wang JH Bauer Y Li Z Shao FS Zetoune E Cattaneo C Vincenz, J Biol Chem 2001 276 33812 33820 10.1074/jbc.M010548200 11451944
45. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. P Li D Nijhawan I Budihardjo SM Srinivasula M Ahmad ES Alnemri X Wang, Cell 1997 91 479 489 10.1016/S0092- 8674(00)80434-1 9390557
46. Pro-caspase-3 is a major physiologic target of caspase-8. HR Stennicke JM Jürgensmeier H Shin Q Deveraux BB Wolf X Yang Q Zhou HM Ellerby LM Ellerby D Bredesen DR Green JC Reed CJ Froelich GS Salvesen, J Biol Chem 1998 273 27084 27090 10.1074/jbc.273.42.27084 9765224
47. The p75(NTR) tumor suppressor induces caspase-mediated apoptosis in bladder tumor cells. A Tabassum F Khwaja D Djakiew, Int J Cancer 2003 105 47 52 10.1002/ijc.11038 12672029
48. Identification of chelerythrine as an inhibitor of BclXL function. SL Chan MC Lee KO Tan LK Yang AS Lee H Flotow NY Fu MS Butler DD Soejarto AD Buss VC Yu, J Biol Chem 2003 278 20453 20456 10.1074/jbc.C300138200 12702731
49. Parkinson's disease/mechanisms and models. W Dauer S Przedborski, Neuron 2003 39 889 909 10.1016/S0896-6273(03)00568-3 12971891
50. Parkinson disease in twins/an etiologic study. CM Tanner R Ottman SM Goldman J Ellenberg P Chan R Mayeux JW Langston, JAMA 1999 281 341 346 10.1001/jama.281.4.341 9929087
51. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. S Kaul A Kanthasamy M Kitazawa V Anantharam AG Kanthasamy, Eur J Neurosci 2003 18 1387 1401 10.1046/j.1460-9568.2003.02864.x 14511319
52. 6-Hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. Q Liang AK Liou Y Ding G Cao X Xiao RG Perez J Chen, J Neurosci Res 2004 77 747 761 10.1002/jnr.20198 15352222
53. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells. M Watabe T Nakaki, J Pharmacol Exp Ther 2004 311 948 953 10.1124/jpet.104.071381 15280438
54. Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions. HK Choi L Won JD Roback BH Wainer A Heller, Proc Natl Acad Sci USA 1992 89 8943 8947 1357658 10.1073/pnas.89.19.8943
55. Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c. M Deshmukh EM Johnson Jr, Neuron 1998 21 695 705 10.1016/S0896-6273(00)80587-5 9808457
56. Mitochondrial control of apoptosis: the role of cytochrome c. J Cai J Yang DP Jones, Biochim Biophys Acta 1998 1366 139 149 10.1016/S0005-2728(98) 00109-1 9714780
57. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. HK Lorenzo SA Susin J Penninger G Kroemer, Cell Death Differ 1999 6 516 524 10.1038/sj.cdd.4400527 10381654
58. TrkB signalling inhibits p75-mediated apoptosis induced by nerve growth factor in embryonic proprioceptive neurons. F Davey AM Davies, Curr Biol 1998 8 915 918 10.1016/S0960-9822(07)00371-5 9707403
59. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Z Xia M Dickens J Raingeaud RJ Davis ME Greenberg, Science 1995 270 1326 1331 10.1126/science.270.5240.1326 7481820
60. Association of protein kinases ERK1 and ERK2 with p75 nerve growth factor receptors. C Volente JM Angelastro LA Greene, J Biol Chem 1993 268 21410 21415 8407983
61. Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death. C Costantini F Rossi E Formaggio R Bernardoni D Cecconi V Della-Bianca, J Mol Neurosci 2005 25 141 156 10.1385/JMN:25:2:141 15784962
62. Focal cerebral ischemia in rats induces expression of P75 neurotrophin receptor in resistant striatal cholinergic neurons. Z Kokaia G Andsberg A Martinez-Serrano O Lindvall, Neuroscience 1998 84 1113 1125 10.1016/S0306- 4522(97)00579-4 9578399
63. Haploin-sufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra. O von Bohlen und Halbach L Minichiello K Unsicker, Faseb J 2005 19 1740 1742 16037097
64. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons. MJ Porritt PE Batchelor DW Howells, Exp Neurol 2005 192 226 234 10.1016/j.expneurol.2004.11.030 15698637
65. Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease. JR Pineda JM Canals M Bosch A Adell G Mengod F Artigas P Ernfors J Alberch, J Neurochem 2005 93 1057 1068 10.1111/j.1471-4159.2005.03047.x 15934928
66. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. NA Tatton, Exp Neurol 2000 166 29 43 10.1006/exnr.2000.7489 11031081
67. The transcription factor PITX3 is associated with sporadic Parkinson's disease. J Fuchs JC Mueller P Lichtner C Schulte M Munz D Berg U Wullner T Illig M Sharma T Gasser, Neurobiol Aging 2007 17905480